FDA Investigator Jonah S Ufferfilge

Jonah S Ufferfilge has inspections in 2 countries as of 20 Oct 2023. Jonah S Ufferfilge has collaborated with a combinined 3668 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
34
Last Inspection Date:
20 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India
Co-Investigator(s):
Adetutu M Gidado, Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Allison A Aldridge, PhD, Amber G Wardwell, Amy C Jordan, Amy N Chen, Anastasia M Shields, Andrew M Barlow, Angela E Glenn, Annet R Rajan, Anthony C Warchut, Anthony C Warren, Arsen Karapetyan, Barbara A Gullick, Barbara J Maulfair, Barbara M Frazier, Bijoy Panicher, Bijoy Panicker, Brenna L Macdowell, Brooke K Higgins, Brooke K Seeman, Byungja E Marciante, Chaltu N Wakijra, Charisse K Green, Charles I Ann, Charles R Cote, RIC, Cheryl A Clausen, Chiang Syin, PhD, Christina K Theodorou, Christine M Smith, Christopher Janik, Chunsheng Cai, PhD, Claire M Minden, Cody D Rickman, Daniel J Roberts, Darin S Wiegers, David A Oluwo, David P Vanhouten, Dawn L Wydner, Dawn M Braswell, Devaughn Edwards, Deyaa Shaheen, Diane C Thibodeau, Diane M Prince, Dien N Nguyen, Douglas A Campbell, Dr. Dominick Roselle, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. S Nar Ali, PhD, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward J Janik, Edwin Melendez, Elizabeth Walther, Emest F Bizjak, Emily J Schramm, Emmanuel J Ramos, Eric C Schmitt, Eric L Dong, BS, Erik W Koester, Erk W Koester, Felix Maldonado, Gabrielle J Swain, Garry H Stewart, Gayle S Lawson, George Pyramides, Guerlain Ulysse, Gwyn G Dickinson, Hang N Guo, Hector J Colon Torres, Helen B Ricalde, Helen Verdel, James M Mason, James M Simpson, James W Whitney, Janet A Rajan, Jay B Shah, Jeffrey P Raimondi, Jogy George, John P Mistler, John S Hartford, Jonah Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose Martinez, Jr, Jose O Hernandez, Jose R Hernandez, Joseph W Matthews, Juliana M Badalucco, June P Page, Junho Pak, Justin A Boyd, Karishma G Gopaul, Kathleen M Jordan, Kenneth Gordon, Kenneth H Williams, Kenneth M Gordon, Kenneth Nieves, Kent A Conforti, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Kimberly M White, Ko U Min, Kristina L Conroy, Laishan L Lam, Lawrence Harmon, Jr, LCDR Debra Emerson, Li Li, Linda L Green, Lori M Newman, Lori S Lawless, Luis A Dasta, M Patriciaurphy Murphy, Maotang Zhou, PhD, Marc S Neubauer, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Margaret M Sands, Mark R Mcclain, Matthew C Watson, Matthew M Henciak, Maya M Davis, Megan A Haggerty, Meisha A Mandal, Melissa J Garcia, Michael A Charles, Michael R Goga, Michael Shanks, MS, Michele Perry Williams, Michelle M Noe, Miguel A Martinez, Monique Rac Lester, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nealie C Newberger, Nebil A Oumer, Nicholas A Violand, Nicole E Knowlton, Niketa Patel, Nina Yang, Parul M Patel, Paula J Bretz, Pei I Chu, Peter R Lenahan, Philip F Istafanos, DMV, MS, Pushpa S Jayasekara, Rachael A Moliver, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Rajiv R Srivastava, Ralph H Vocque, Ramon E Martinez, Rapti D Madurawe, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Rebecca Rodriguez, Robert H Wittorf, Robert J Martin, Robert Mo Brien, Rochelle L Cross, Saleem A Akhtar, Samina S Khan, Samir C Gala, Sandra P White, Sarah E Mcmullen, Sarah E Venti, Scott B Laufenberg, Scott T Ballard, Sean R Marcsisin, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Sixto M Mercado Rios, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Stephen R Souza, Steven D Kehoe, Susanna E Ford, Analyst, Syed N Ali, Teresa I Navas, Thomas E Friel, Thomas J Arista, Thomas R Withers, Tonia F Bernard, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Unnee Ranjan, Victoria M Daddeo, Viviana Matta, Vivin George, Walter L Fava, Wanda Y Honeyblue, William J Leonard, Yaharn Su, Yvins Dezan, Zhongren Wu

Jonah S Ufferfilge's Documents

Publish Date Document Type Title
August, 2022 FDA 483 CIPLA LIMITED - Form 483, 2022-08-26
July, 2021 FDA 483 Response Valisure, LLC - Form 483R, 2021-07-27
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
December, 2019 FDA 483 Response Avista Pharma Solutions, Inc. dba Cambrex - Form 483R, 2020-01-07
December, 2019 EIR Avista Pharma Solutions, Inc. dba Cambrex - EIR, 2019-12-18
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
March, 2021 EIR PINE LAKE INVESTMENTS, INC. - EIR, 2021-03-18
July, 2021 EIR Valisure, LLC - EIR, 2021-07-06
March, 2019 FDA 483 AllerQuest LLC - Form 483, 2019-03-01
September, 2021 FDA 483 Ecometics, Inc. - Form 483, 2021-09-10
November, 2019 FDA 483 Tender Corporation - Form 483, 2019-11-25
February, 2023 FDA 483 Ecometics, Inc. - Form 483, 2023-02-06
October, 2023 FDA 483 Response SCA Pharmaceuticals - Form 483R, 2023-11-10
August, 2019 FDA 483 Roger Williams Medical Center - Form 483, 2019-08-14
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
October, 2022 FDA 483 Unipharm, Inc - Form 483, 2022-10-05
November, 2019 FDA 483 Response Tender Corporation - Form 483R, 2019-12-17
May, 2022 FDA 483 MD Pharmaceutical Supply, LLC - Form 483, 2022-05-09
January, 2022 FDA 483 Greenfield Global USA Inc - Form 483, 2022-01-18
April, 2022 FDA 483 Brookfield Medical/Surgical Supply, Inc. - Form 483, 2022-04-04
April, 2023 FDA 483 Afton Scientific, LLC - Form 483, 2023-04-06
December, 2019 FDA 483 Avista Pharma Solutions, Inc. dba Cambrex - Form 483, 2019-12-18
March, 2020 FDA 483 Response Edge Pharma, LLC - Form 483R, 2020-05-01
May, 2021 FDA 483 Miyoshi America, Inc. - Form 483, 2021-05-25
July, 2021 FDA 483 Valisure, LLC - Form 483, 2021-07-06
March, 2020 FDA 483 Edge Pharma, LLC - Form 483, 2020-03-30
October, 2023 FDA 483 SCA Pharmaceuticals - Form 483, 2023-10-20
April, 2019 FDA 483 Alden Medical LLC - Form 483, 2019-04-23
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
August, 2022 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2022-08-12
September, 2019 FDA 483 Primeline - Form 483, 2019-11-05
September, 2019 FDA 483 Primeline - Form 483, 2019-11-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more